News

Australian government invests $29.1m in HIV response

Australian government invests $29.1m in HIV response

Part of the investment includes $17.2m (A$26m) funding for subsidised access to PrEP medication.

Australia launches comprehensive network for improved cancer care

The ACCN is part of the 10-year Australian Cancer Plan, established in 2023.

KKH unveils Children’s Lipid Centre for familial hypercholesterolemia

The centre focuses on early detection and management of FH in children.

Malaysia’s Island Hospital to expand with $426.3m integrated medical hub

The hub will feature over 1,000 beds and a medical tourism-focused hotel.

Saudi Arabia launches Medical Referral Centre unified platform

The platform supports the country's Vision 2030 for better quality and access to health services.

India’s Amrita Hospital adopts robotic system for enhanced rehabilitation

The system utilises AI to facilitate progress in walking.

Orthopaedic device market to reach $13.91b by 2028

The APAC market expects notable growth due to increasing healthcare expenditure and a large patient pool.

Abu Dhabi to promote training for advanced AI and genomics research

The programme will train 500 Emirati physicians on the responsible and effective use of LLMs.

Global brain computer interface market to reach $506m by 2029

The non-invasive BCI segment held the largest market share in 2023.

Companion diagnostics market foresees 15.2% CAGR until 2028

The global market is estimated to reach $15.4b within the forecast period.

IHH Healthcare unveils proton therapy centre for cancer treatment

The Mount Elizabeth Proton Therapy Centre offers specialised cancer treatment in Singapore.

Australia to establish 5th Medicare UCC in Tasmania

The clinic in Bridgewater is one of the 29 to be established as part of a $152.2m (A$227m) expansion.

Australia implements reform to boost frontline healthcare worker numbers

Phase one of the initiative aims to deliver more nurses and midwives by July 2027.

Burjeel Medical City partners with TII for cancer treatment

The two-year collaboration will focus on engineering T-cell-based therapeutics and TIL therapy.